Form 8-K Expedia, Inc. For: Jul 31
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140731/AP22H22EZZ2RTTZZ2RZM2ZXLBKKGEZ22Z26G
Filed on: July 31, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma
- Definium Therapeutics to Discuss Topline Results from Phase 3 Emerge Study in Major Depressive Disorder on June 22, 2026
- Syntax Bio Announces Expanded Series A and Leadership Appointments
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
